Document Detail


Weak BMAA toxicity compares with that of the dietary supplement beta-alanine.
MedLine Citation:
PMID:  21236519     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Beta-N-methylamino-l-alanine (BMAA) is routinely described in the literature as a potent neurotoxin and as a possible cause of neurodegenerative disorders of aging such as Alzheimer's disease, amyotrophic lateral sclerosis, and the amyotrophic lateral sclerosis/parkinsonism-dementia complex (ALS-PDC) syndrome of Guam. To test for the toxicity of BMAA against human neurons, we chose 3 standard human neuronal cell lines for examination and compared the toxicity with the muscle-building nutritional supplement β-alanine, glutamic acid, and the established excitotoxins kainic acid, quisqualic acid, ibotenic acid, domoic acid, and quinolinic acid. Neurotoxicity was measured by the standard lactic dehydrogenase release assay after 5-day incubation of NT-2, SK-N-MC, and SH-SY5Y cells with BMAA and the comparative substances. The ED(50) of BMAA, corresponding to 50% death of neurons, varied from 1430 to 1604 μM while that of the nutritional supplement β-alanine was almost as low, varying from 1945 to 2134 μM. The ED(50) for glutamic acid and the 5 established excitotoxins was 200- to 360-fold lower, varying from 44 to 70 μM. These in vitro data are in accord with previously published in vivo data on BMAA toxicity in which mice showed no pathological effects from oral consumption of 500 mg/kg/day for more than 10 weeks. Because there are no known natural sources of BMAA that would make consumption of such amounts possible, and because the toxicity observed was in the same range as the nutritional supplement β-alanine, the hypothesis that BMAA is an environmental hazard and a contributor to degenerative neurological diseases becomes untenable.
Authors:
Moonhee Lee; Patrick L McGeer
Related Documents :
7383489 - Amniotic fluid bile acids in normal and pathologic pregnancy.
7970149 - Extreme stability of tyr-mif-1 in csf.
7520379 - Association of cerebrospinal fluid deficiency of 5-methyltetrahydrofolate, but not s-ad...
9004939 - Reference values of neuroactive amino acids in the cerebrospinal fluid by high-performa...
2580329 - Decrease in dopamine, its metabolites and noradrenaline in cerebrospinal fluid of schiz...
1962529 - Effects of guilingji on brain monoamines and their metabolites in mice.
1229719 - The phenolics of fruits. vii. the phenolics of cherries and plums and the changes in ca...
24227489 - Attractiveness to mexican fruit flies of combinations of acetic acid with ammonium/amin...
6473259 - Biological efficacy of liquid methionine and methionine hydroxy analogue-free acid in c...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-1-12
Journal Detail:
Title:  Neurobiology of aging     Volume:  -     ISSN:  1558-1497     ISO Abbreviation:  -     Publication Date:  2011 Jan 
Date Detail:
Created Date:  2011-1-17     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8100437     Medline TA:  Neurobiol Aging     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2011 Elsevier Inc. All rights reserved.
Affiliation:
Kinsmen Laboratory of Neurological Research, University of British Columbia, Vancouver, BC, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  CSF ?-synuclein does not differentiate between parkinsonian disorders.
Next Document:  Comparison of family functioning profile in adolescents with and without drug-dependency in a high s...